Ulrich Herrlinger
Overview
Explore the profile of Ulrich Herrlinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
5221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Friedrich M, Werner J, Steinbach J, Sabel M, Herrlinger U, Piroth M, et al.
Neurooncol Adv
. 2025 Mar;
7(1):vdaf023.
PMID: 40084168
Background: Amino acid PET using the tracer -(2-[F]fluoroethyl)-l-tyrosine (FET) is one of the most reliable imaging methods for detecting glioma recurrence. Here, we hypothesized that functional MR connectivity between the...
2.
Schneider M, Potthoff A, Ahmadipour Y, Borger V, Clusmann H, Combs S, et al.
BMC Cancer
. 2025 Feb;
25(1):306.
PMID: 39979825
Background: The discovery of cellular tumor networks in glioblastoma, with routes of malignant communication extending far beyond the detectable tumor margins, has highlighted the potential of supramarginal resection strategies. Retrospective...
3.
Talpin A, Maia A, Carpier J, Kulakowski G, Aubergeon L, Kervevan J, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39979071
Background: Molecular mimicry between commensal bacterial antigens and tumor-associated antigens (TAAs) has shown potential in enhancing antitumor immune responses. This study leveraged this concept using commensal bacterial antigens, termed OncoMimics,...
4.
Zeyen T, Weller J, Schneider M, Potthoff A, Schaub C, Roever L, et al.
Neurooncol Adv
. 2025 Feb;
7(1):vdaf005.
PMID: 39902392
Background: Polychemotherapy based on high-dose methotrexate (HD-MTX) is the standard therapy for newly diagnosed younger patients (<65 years) with primary CNS lymphoma (PCNSL). In the modified Bonn protocol, consolidation therapy...
5.
Friker L, Perwein T, Waha A, Dorner E, Klein R, Blattner-Johnson M, et al.
Acta Neuropathol
. 2025 Feb;
149(1):11.
PMID: 39894875
Pediatric high-grade glioma (pedHGG) can occur as first manifestation of cancer predisposition syndromes resulting from pathogenic germline variants in the DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1, and PMS2....
6.
Schmidt E, Evert B, Pregler B, Melhem A, Hsieh M, Raspe M, et al.
Mol Oncol
. 2024 Dec;
19(3):878-898.
PMID: 39680504
Glioblastoma cells rely on connexin 43 (Cx43)-based gap junctions (GJs) for intercellular communication, enabling them to integrate into a widely branched malignant network. Although there are promising prospects for new...
7.
Shabo E, Potthoff A, Zeyen T, Layer J, Ehrentraut S, Scorzin J, et al.
J Neurooncol
. 2024 Nov;
171(3):681-689.
PMID: 39607570
Purpose: Prophylactic insertion of an external ventricular drainage (EVD) prior to the resection of posterior fossa metastases (PFMs) is a common approach to address postoperative transient and permanent hydrocephalus. However,...
8.
Weller J, Kocakavuk E, Pregler B, Zeyen T, Schafer N, Potthoff A, et al.
Neuro Oncol
. 2024 Nov;
27(1):306-308.
PMID: 39545540
No abstract available.
9.
Bauer T, Olbrich S, Groteklaes A, Lehnen N, Zidan M, Lange A, et al.
Epilepsia
. 2024 Oct;
65(12):3607-3618.
PMID: 39470733
Objective: High-field magnetic resonance imaging (MRI) is a standard in the diagnosis of epilepsy. However, high costs and technical barriers have limited adoption in low- and middle-income countries. Even in...
10.
Gessler F, Hajdari S, Potthoff A, Bernstock J, Herrlinger U, Czabanka M, et al.
J Neurosurg
. 2024 Oct;
142(3):722-730.
PMID: 39393103
Objective: Visual acuity (VA) constitutes an important outcome measure in surgery for medial sphenoid wing meningioma (SWM). This study aimed to assess the recovery of tumor-associated impairment of VA and...